Humanigen Takes Aim At IL-6 Inhibitors With CRS Drug Lenzilumab
Company Targets COVID-19, CAR-T, GvHD Markets
Roche's Actemra is a major player in this space, but Humanigen is looking to take it on directly.
You may also be interested in...
With elderly patients disproportionately facing hospitalization and death from COVID-19, success in the clinic would create an important market for the drug.
Plus Takeda starts vaccine trial in Japan and South Korea clears Celltrion's antibody therapeutic.
Join us for an audio catch-up on the latest key developments in the global biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.